Kinetic analysis of drug release from nanoparticles

被引:275
作者
Barzegar-Jalali, Mohammad [1 ,2 ]
Adibkia, Khosro [2 ,3 ]
Valizadeh, Hadi [4 ]
Shadbad, Mohammad Reza Siahi
Nokhodchi, Ali [5 ,6 ]
Omidi, Yadollah [2 ]
Mohammadi, Ghobad [7 ]
Nezhadi, Somayeh Hallaj [8 ]
Hasan, Maryam [8 ]
机构
[1] Tabriz Univ Med Sci, Dept Pharmaceut, Sch Pharm, Fac Pharm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Res Ctr Pharmaceut Nanotechnol, Tabriz, Iran
[3] Zanjan Univ Med Sci, Sch Pharm, Zanjan, Iran
[4] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran
[5] Univ Kent, Medway Sch Pharm, Chatham, Kent, England
[6] Univ Greenwich, Medway Sch Pharm, Chatham, Kent, England
[7] Kermanshah Univ Med Sci, Sch Pharm, Kermanshah, Iran
[8] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
来源
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES | 2008年 / 11卷 / 01期
关键词
D O I
10.18433/J3D59T
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
PURPOSE. Comparative drug release kinetics from nanoparticles was carried out using conventional and our novel models with the aim of finding a general model applicable to multi mechanistic release. Theoretical justification for the two best general models was also provided for the first time. METHODS. Ten conventional models and three models developed in our laboratory were applied to release data of 32 drugs from 106 nanoparticle formulations collected from literature. The accuracy of the models was assessed employing mean percent error (E) of each data set, overall mean percent error (OE) and number of Es less than 10 percent. RESULTS. Among the models the novel reciprocal powered time (RPT), Weibull (W) and log-probability (LP) ones produced OE values of 6.47, 6.39 and 6.77, respectively. The OEs of other models were higher than 10%. Also the number of errors less than 10% for the models was 84.9, 80.2 and 78.3 percents of total number of data sets. CONCLUSIONS. Considering the accuracy criteria the reciprocal powered time model could be suggested as a general model for analysis of multi mechanistic drug release from nanoparticles. Also W and LP models were the closest to the suggested model RPT.
引用
收藏
页码:167 / 177
页数:11
相关论文
共 64 条
[1]   Piroxicam nanoparticles for ocular delivery: Physicochemical characterization and implementation in endotoxin-induced uveitis [J].
Adibkia, Khosro ;
Shadbad, Mohammad Reza Siahi ;
Nokhodchi, Ali ;
Javadzedeh, Alireza ;
Barzegar-Jalali, Mohammad ;
Barar, Jaleh ;
Mohammadi, Ghobad ;
Omidi, Yadollah .
JOURNAL OF DRUG TARGETING, 2007, 15 (06) :407-416
[2]   Recent advances on chitosan-based micro- and nanoparticles in drug delivery [J].
Agnihotri, SA ;
Mallikarjuna, NN ;
Aminabhavi, TM .
JOURNAL OF CONTROLLED RELEASE, 2004, 100 (01) :5-28
[3]  
Arayne MS, 2007, PAK J PHARM SCI, V20, P251
[4]   Nanoparticles with specific bioadhesive properties to circumvent the pre-systemic degradation of fluorinated pyrimidines [J].
Arbós, P ;
Campanero, MA ;
Arangoa, MA ;
Irache, JM .
JOURNAL OF CONTROLLED RELEASE, 2004, 96 (01) :55-65
[5]   Kinetic analysis of chlorpropamide dissolution from solid dispersions [J].
Barzegar-Jalali, Mohammad ;
Dastmalchi, Siavoush .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2007, 33 (01) :63-70
[6]  
BARZEGARJALALI MA, 1990, INT J PHARMACEUT, V63, pR6
[7]   Thermally responsive core-shell nanoparticles self-assembled from cholesteryl end-capped and grafted polyacrylamides: drug incorporation and in vitro release [J].
Chaw, CS ;
Chooi, KW ;
Liu, XM ;
Tan, CW ;
Wang, L ;
Yang, YY .
BIOMATERIALS, 2004, 25 (18) :4297-4308
[8]   In vitro and in vivo study of two types of long-circulating solid lipid nanoparticles containing paclitaxel [J].
Chen, DB ;
Yang, TZ ;
Lu, WL ;
Zhang, Q .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2001, 49 (11) :1444-1447
[9]   Modeling and comparison of dissolution profiles [J].
Costa, P ;
Manuel, J ;
Lobo, S .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 13 (02) :123-133
[10]   Encapsulation of 9-nitrocamptothecin, a novel anticancer drug, in biodegradable nanoparticles: Factorial design, characterization and release kinetics [J].
Derakhshandeh, K. ;
Erfan, M. ;
Dadashzadeh, S. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2007, 66 (01) :34-41